Although the disorder is rare, with a prevalence of one to 10 cases per million in adults and one to 3.2 cases per million in children, early recognition and treatment are important ways to decrease the morbidity of systemic complications. Dermatomyositis is an idiopathic inflammatory myopathy with characteristic skin manifestations. Complete list of side effects of plaquenil Hydroxychloroquine plaquenil uses Plaquenil classification Plaquenil retinopathy visual field An increased incidence of cutaneous reactions to hydroxychloroquine has been postulated to occur in patients with dermatomyositis. OBJECTIVE To determine if adverse cutaneous eruptions due to hydroxychloroquine are more common in patients with dermatomyositis than in those with cutaneous lupus erythematosus. Hydroxychloroquine may reduce the photosensitive rash. Note that adverse cutaneous reactions to hydroxychloroquine are reported to affect more than 30% of patients with dermatomyositis, compared to a lower risk of rash in patients with cutaneous lupus erythematosus 1. Dr. Werth Sometimes the rash can improve with plaquenil. The dose of CellCept might need to be as high as 3000 mg/day. The dose of CellCept might need to be as high as 3000 mg/day. IVIG works best if given every 4 weeks, so if you get better for a while and then worse before the next IVIG treatment, you might need to get the IVIG more often. Poor prognostic indicators include poorly responsive disease, delay in diagnosis and the presence of malignancy. Patient management includes careful evaluation for underlying malignancy and liberal use of physical therapy, antihistamines, sunscreen and oral corticosteroids. Dermatomyositis hydroxychloroquine rash Dermatomyositis - NORD National Organization for Rare Disorders, Dermatomyositis DermNet NZ Is hydroxychloroquine a controlled substancePlaquenil surgery healing Nov 01, 2001 Heliotrope, a macular rash with periorbital edema, is considered a characteristic finding of dermatomyositis, as are periungual telangiectasias Figure 2. 1,8 The rash occurs early in the course of the disease in 30 to 60 percent of patients. Dermatomyositis - American Family Physician. Myositis Skin Care and Treatment The Myositis Association. Skin Care for Myositis The Myositis Association. Plaquenil hydroxychloroquine is an antimalarial medication used to treat or prevent malaria, a disease caused by parasites, which enter the body through the bite of a mosquito. Plaquenil is also used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. Juvenile Dermatomyositis JDM Juvenile dermatomyositis JDM is a disease in children that causes skin rash dermato and muscle inflammation myositis, resulting in weak muscles. JDM is a type of autoimmune disease. The immune system is a group of cells that protect the body from infections. Dermatomyositis dermato = skin; myositis = muscle is an autoimmune condition that characteristically causes a skin rash and muscle weakness. Autoimmune diseases occur when the body’s immune system which normally protects you from infections and cancer begins to act abnormally and mistakenly attacks normally-functioning parts of your body, leading to inflammation of various body tissues and internal organs.